Thomas J. Bardos Biography

The AACR-Thomas J. Bardos Science Education Awards for Undergraduate Students are named for Thomas J. Bardos, Ph.D. These awards have been supported by generous annual contributions from Dr. Bardos, a distinguished member of the AACR, since their inception in 1997. Dr. Bardos' contributions are subsequently matched by those of AACR. 

During his 33 year University of Buffalo career, Professor Bardos coauthored more than 200 peer-reviewed chapters and papers on cancer chemotherapy, including work on anti-metabolites and dual antagonists. At his University of Buffalo lab, he directed the thesis research of a total of 32 Ph.D. candidates and the research projects of 38 postdoctoral associates.

In addition to numerous invited seminar presentations at universities and research labs in the United States and Europe, he was a participant in several international symposia on nucleic acids and cancer, and was invited to participate in international lecture tours by the Indian Association for the Cultivation of Science, the Australian Chemical Institute and the Chinese Academy of Sciences.
His research attracted several prestigious awards including a Fellowship in the New York Academy of Science, the 1971 Ebert Prize of the American Pharmaceutical Association, and the 1974 Jacob F. Schoellkopf Medal of the Western New York American Chemical Society for his contributions to chemotherapeutic treatment of cancer. In 1983 he was elected an honorary member of the Hungarian Academy of Sciences.

Professor Bardos retired in 1993. Since his retirement, he has received the new designations "MRSC" from the Royal Society of Chemistry in 2001 and "Visionary Innovator" from the University of Buffalo Office of Science, Technology Transfer, and Economic Outreach in 2004.

Dr. Bardos passed away in 2012. The Board of Directors of the AACR expresses its deep appreciation to Dr. Bardos for his foresight, leadership, and generosity in encouraging the creation of the Science Education Awards program, and in sustaining this important program.